About
Small molecule for ophthalmology
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
546
By Phase
PHASE2: 5PHASE1/PHASE2: 2
By Status
COMPLETED: 3ACTIVE_NOT_RECRUITING: 2NOT_YET_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06463678Lead Sponsor
Trial to Evaluate the Efficacy And Safety of IVIEW-1201 In the Treatment of Fungal Keratitis
PHASE2Not yet recruiting
60 participants
Started: Aug 1, 2026 · Completed: Dec 31, 2027
NCT06921317Lead Sponsor
GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma
PHASE1/PHASE2Recruiting
12 participants
Started: Oct 31, 2025 · Completed: Feb 28, 2027
NCT07161011Lead Sponsor
Phase 2b Controlled Study of Dosing Techniques - Part B
PHASE2Active, not recruiting
30 participants
Started: Sep 8, 2025 · Completed: Dec 31, 2025
NCT07140380Lead Sponsor
Phase 2b Controlled Study
PHASE2Active, not recruiting
30 participants
Started: Aug 20, 2025 · Completed: Dec 31, 2025
NCT06400459Lead Sponsor
IVW-1001 Phase 1/2 in Subjects With Dry Eye Disease
PHASE1/PHASE2Completed
150 participants
Started: Jun 25, 2024 · Completed: Oct 15, 2024
Locations (1)
Headquarters
Cranbury, NJ, United States
Map
Loading map...